PhRMA Lobby Names Corporate Heavyweight John Castellani As Chief

WASHINGTON, July 13 (Reuters) - The U.S. drug industry named a top corporate lobbyist on Tuesday to head its trade association, a move that analysts said could mean a tougher approach on healthcare issues by big pharma.